tiprankstipranks
Trending News
More News >
AbbVie (ABBV)
NYSE:ABBV
US Market

AbbVie (ABBV) Technical Analysis

Compare
22,444 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is -5.76, suggesting AbbVie is a Sell.
AbbVie’s (ABBV) 20-Day exponential moving average is 183.17, while AbbVie’s (ABBV) share price is $186.06, making it a Buy.
AbbVie’s (ABBV) 50-Day exponential moving average is 188.95, while AbbVie’s (ABBV) share price is $186.06, making it a Sell.

AbbVie (ABBV) Pivot Points

Apr 28, 2025, 06:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
171.78
173.94
177.16
179.32
182.54
184.70
187.92
Fibonacci
173.94
176.00
177.27
179.32
181.38
182.65
184.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

Apr 28, 2025, 06:24 AM
Period
Simple
Exponential
MA5
177.48Buy
179.70Buy
MA10
175.98Buy
179.01Buy
MA20
183.66Buy
183.17Buy
MA50
196.46Sell
188.95Sell
MA100
186.20Sell
187.72Sell
MA200
184.96Buy
183.26Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 179.01, while AbbVie’s (ABBV) share price is $186.06, making it a Buy.
AbbVie’s (ABBV) 100-Day exponential moving average is 187.72, while AbbVie’s (ABBV) share price is $186.06, making it a Sell.
AbbVie’s (ABBV) stock price is $186.06 and AbbVie’s (ABBV) 50-day simple moving average is 196.46, creating a Sell signal.
AbbVie’s (ABBV) stock price is $186.06 and AbbVie’s (ABBV) 100-day simple moving average is 186.20, creating a Sell signal.
AbbVie’s (ABBV) stock price is $186.06 and AbbVie’s (ABBV) 200-day simple moving average is 184.96, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

Apr 28, 2025, 06:24 AM
Name
Value
Implied Action
RSI (14)
50.39
Neutral
STOCH (9,6)
85.35
Sell
STOCHRSI (14)
53.79
Neutral
MACD (12,26)
-5.76
Sell
ADX (14)
37.43
Neutral
Williams %R
-10.86
Sell
CCI (14)
4.17
Neutral
ATR (14)
7.03
-
Ultimate Oscillator
52.68
Neutral
ROC
0.44
Buy
AbbVie’s (ABBV) Relative Strength Index (RSI) is 50.39, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 37.43, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is 4.17, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is 0.44, creating a Buy signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Buy.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 50.39, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is -5.76, which suggests ABBV is a Sell.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 177.48, which suggests ABBV is a Buy.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 183.66, which suggests ABBV is a Buy.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 196.46, which suggests ABBV is a Sell.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 184.96, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -10.86, which suggests ABBV is a Sell.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is 4.17, which suggests ABBV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis